Medical Weight Loss
Revolutionary glucagon-like peptide-1 (GPL-1) receptor blocker medications help you kick start your weight loss journey. If you are obese with a Body Mass Index (BMI) of over 30 or overweight with a BMI of 27 and above and have other risk factors, you could qualify for our 12 weeks program. Medications such as Semaglutide and Mounjaro stimulate insulin secretion in a glucose-dependent manner, slow the gastric motility, increase insulin sensitivity, decrease glucagon secretion and improve early satiety.
Benefits:
Injections are once a week done either virtually or in office for a minimum of 12 weeks.
Packages:
Frequently Asked Questions (FAQ)
Yes! Semaglutide received FDA approval for chronic weight management in adults with obesity or overweight conditions in 2021.
Injections are administered once a week, either virtually or in-office, for a minimum of 12 weeks. Our program includes an initial consultation, three-six months of medication and supplies, monthly video consultations, and personalized nutritional recommendations.
Our program is designed to promote sustainable weight loss through healthy lifestyle changes. Individual results can vary, and our medical team will work with you to set realistic and achievable goals based on your specific circumstances and health needs. Typically, participants may see a weight loss of 1-3 pounds per week. While results may vary, those who continue to follow the recommended diet and exercise plan often maintain their weight loss long-term.
To get started, schedule a consultation with our office. During this session, we will evaluate your health, discuss your weight loss goals, and determine your eligibility for the program. Once approved, we will guide you through every step of the process to ensure you achieve the best possible results.